Spectral discrimination of Cerenkov radiation in scintillating dosimeters

Radiation therapy accelerators require highly accurate dose deposition and the output must be monitored frequently and regularly. Ionization chambers are the primary tool for this control, but their size, their high voltage needed, and the correction needed for electrons make them unsuitable for use during patient treatment. We have developed a small (1-mm-diam and 1-mm-long active part), flexible, and water-equivalent dosimeter. It is suitable for photon and electron beams without corrections, and performs on line dose measurements. This detector is based on only one scintillating fiber and a CCD camera. A new signal processing is used to remove the effect of Cerenkov radiation background, which only requires a preliminary calibration. Central-axis depth-dose distribution comparisons have been achieved with standard ionization chambers, over a range from 8 to 25 MV photons and from 6 to 21 MeV electrons in order to validate this calibration. Results show a very good agreement, with less than 1% difference between the two detectors.     

An autopsy case of mitochondrial encephalomyopathy (MELAS) with special reference to extra-neuromuscular abnormalities.

An autopsy case of a 37-year-old man with mitochondrial encephalomyopathy is reported. Ragged-red fibers and crystalline inclusions in mitochondria were revealed by biopsy of the striated muscle of the patient. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) was diagnosed clinically. In addition to severe atrophy and degeneration of the generalized striated muscles and many foci of laminar necrosis of the cerebral cortex, the following abnormalities were observed: 1) hypertrophy of the myocardium, 2) fatty change of the liver, 3) focal sclerosis of the glomeruli and dilatation of the tubules of the kidneys, 4) hyalinous degeneration of the Langerhans' islands of the pancreas and 5) wavy change of the smooth muscle fibers of the muscularis propria of the gastrointestinal tract. We suggest that mitochondrial encephalomyopathy affects various organs and tissues, among which susceptibility of the muscular tissues--skeletal muscle, myocardium and smooth muscle--is high.     

Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles

Summary The effects of atenolol (2–5 mmol/l), sotalol (1–2 mmol/l) and pamatolol (0.1–1 mmol/l), together with N-tertiary butyl phenoxypropanolamines with o-methyl (D-2T: 50–100 mol/l) m-methyl (D-3T: 50–100 mol/l) and p-methyl (D-4T:100–200 mol/l) group as well as with o,p-methyl groups (D-24T) (50–100 mol/l) on action potentials (APs) were investigated in isolated guinea-pig papillary muscles. All the drugs in these concentrations produced a concentration-dependent reduction of the maximum upstroke velocity (V _max). The reduction ofV _max in premature APs induced by stimuli interpolated between the basic driving rate of 0.25, 0.1 or 0.027 Hz decayed exponentially during diastolic intervals. The time constants of these decay processes for atenolol, pamatolol and sotalol ranged between 260–541 ms, those for D-3T and D-4T between 655–1,166 ms, and D-2T and D-24T between 1,565–1,931 ms. A drug which provided larger values caused the reduction ofV _max in a wider range of the frequency. With respect to the aryloxypropanolamine derivatives so far studied (Sada and Ban 1980, 1981 a, b; Sada et al. 1983) fairly good correlations were found as follows: between logn-octanol/water partition coefficient (logP) and ED₂₀ at 0.25 Hz, ED₃₀ at 1 and 4 Hz for 11–14 compounds; between logP and resting block, between molecular weight and A _o ^c i.e. the value extrapolated to the time of APD₉₀ of the conditioning response relative to the predrugV _max value which may represent a fraction of channels blocked per AP for 100 mol/l of 20–22 compounds. With respect to 8 compounds with methyl substituents in the benzene ring or amine part the ortho methyl group makes a major contribution to increase the resting block and to increase log values.     

东菱精纯克栓酶对荷瘤裸鼠全血Casson值的影响

为观察并了解东菱精纯克栓酶对荷瘤裸鼠全血Casson值的影响,采用锥板式粘度计对移植了胃癌和鼻咽癌的荷瘤裸鼠使用东菱精纯克栓酶前后的全血粘度进行检测,并采用线性回归的方法求出各组Casson粘度(CV)及Casson屈服值(CY)。结果显示,使用东菱精纯克栓酶后两组荷瘤裸鼠全血(CV)值皆明显下降(P＜0.01);(CY)值在胃癌组明显下降(P＜0.01),鼻咽癌组无明显变化(P＞0.05)。结果表明,使用东菱精纯克栓酶对荷瘤裸鼠的血液流变学参数有明显改善,提示有可能将其应用于临床预防肿瘤转移及扩散。     

动态研究HBV和AFB1诱发树鼠句肝细胞癌过程中一些基因的表达

目的：探讨人乙肝病毒(HBV)和黄曲霉毒素B,(AFB1)致肝细胞癌(HCC)及协同致HCC作用的机制。方法：将树鼩分为4组：A组：感染HBV加摄入AFB,;B组：只感染HBV;C组：只摄入AFB1;D组：作空白对照。然后定期行肝活检,用免疫组化、分子生物学等技术动态观察一些癌基因(蛋白)和抑癌基因的表达。结果：①A组谷胱苷肽转移酶(GGT)阳性灶个数及面积明显多于、大于B、C组;②A组P21蛋白检出率明显高于B和C组,A组6只P21蛋白阳性的树鼩到120周时全部发生了HCC;③实验后期,A组HBxAg检出率及HBVDNA整合率明显高于B组;④在诱癌过程中,IGF-Ⅱ表达率呈波动形,带癌肝的表达率显著高于无癌肝;⑤105周时,A、B、C组P53蛋白表达率显著高于D组;在A,C组检出P53异常带;⑥第45及105周时,A组c-fos表达率分别为23．1％和20％;C组为38．5％和15．4％,B,D两组均未检出;⑦H-c-myc基因：直到120周,无癌肝组织均未见异常;在肝癌组织中,A组有4例扩增,c组无异常;@CDK4基因：只有A组在第75周有1例扩增,该树鼩在第106周时发生了HCC。在HCC中,A组有25％出现CDK。扩增,C组未见异常。结论：再次证实HBV和AFB。有协同致HCC作用;AFB、有利于HBxAg的表达和HBVDNA的整合;CDK4、Kiras和P53基因的变异参与了HCC的发生和演进;P21和c-fos蛋白的过表达与P^53蛋白的失活,促进了HCC的发生和演进;CDK4和c-myc基因的改变与HBV的感染有一定的关联。     

准分子激光角膜原位磨镶术治疗高度近视疗效分析

目的:观察准分子激光角膜原位磨镶术(LASIK)治疗高度近视的疗效.方法:采用LASIK治疗高度近视眼(平均-11.2±1.86D)195只,术后第1,6,12个月随访观察.结果:术后第1,6,12个月裸眼视力达到0.5和1.0者分别为84.1%,79.0%,74.9%和61.0%,57.9%,55.9%;术后第1,6,12个月屈光度在预测矫正度±0.50D和±1.0D者分别是68.7%,63.1%,61.5%和79.0%,75.9%和74.9%.结论:LASIK治疗高度近视有较好的效果,手术中并发症与术者手术技巧有关.     

1981-1993年杭州口岸航空食品卫生细菌检测分析

本文报导了自1981年-1993年对杭州→香港中国民航航班及港龙航空公司航班,九大类供机食品卫生监督检验结果及分析.按不同年份,各类食品,不同检验项目以及不同航空公司配餐食品卫生质量分别作了比较.共检供机食品969份,合格535份,不合格434份,总合格率为55.21%.不同食品的合格率比较,合格率最高的是糕点为75.22%,其次为面饭为74.32%,合格率最低的是色拉为11.11%.     

Evaluation of a compressive-type skeletal muscle pump for cardiac assistance

BACKGROUND: Recent investigations have focused on using the latissimus dorsi muscle for cardiac assistance. Although cardiomyoplasty has been applied clinically, other procedures remain experimental, but promising, modes of cardiac assistance. We assessed the latissimus dorsi muscle as an in situ energy source for circulatory assist devices. METHODS: We developed a pneumatic chamber as a compressive-type muscle actuator. The chamber was implanted under the latissimus dorsi muscle and converted contractile power into pneumatic pressure. The effect of chamber position and size and the influence on muscle blood flow were examined. After muscle conditioning, the pump performance of a circulatory assist device driven by the chamber was evaluated. RESULTS: The chamber functioned better when placed in the proximal position of the latissimus dorsi muscle. The size affected the generated pneumatic pressure, and the higher resting pressure of the chamber reduced the muscle blood flow. The maximum stroke work of the circulatory assist device was greater than that of the right ventricle but less than that of the left ventricle. The chamber could drive the circulatory assist device against the systemic range of afterload in which a high preload was available. Long-term adhesion surrounding the chamber reduced the pressure generation capability. CONCLUSIONS: The compressive-type muscle actuator using the latissimus dorsi muscle generated acceptable hemodynamic work for right ventricular bypass or aortic counterpulsation.     

对我国卫生资源配置和使用几个深层次问题的思索

我国卫生资源既分管又浪费成为业内人士的共识,但它又是一个困扰我国卫生事业发展的实际而又紧迫的问题,这个问题解决不了,就会降低我国卫生资源的使用效率。作者认为：要使我国有限的卫生资源以充分而合理地使用好,就要立足于我国的基本国情,在确保市场的微观调节的前提下,必须运用政府的宏观调控行为和政策指导手段,尽可能为管理体制的改革扫除障碍,同时在卫生资源的配置问题上引入法制机制。     

Immunological comparison between prostate-specific antigen and γ-seminoprotein

Summary Prostate-specific antigen (PA) and -seminoprotein (-Sm) were compared by immunocytochemical, immunodiffusion and immunoblotting methods using rabbit anti-PA antibody and rabbit anti--Sm antibody. Enzyme immunoassys (EIAs) were developed for measurements of PA and -Sm to determine a correlation between serum PA and -Sm levels in patients with prostate cancer. The patterns of localization and distribution of PA and -Sm were identical in prostate tissue sections, including benign and cancerous human prostacs. The immunodiffusion study showed that the antigens with which anti-PA antibody and anti--Sm antibody reacted in seminal plasma and prostate tissue homogenates were identical to each other. In the immunoblotting study, anti-PA antibody and anti--Sm antibody recognized a single antigen corresponding to a molecular weight of approximately 33,000 both in seminal plasma and prostate tissue homogenates. The EIAs developed in this study were sensitive, specific, and reproducible, and the correlation between serum PA and -Sm values determined by these EIAs was highly significant (r=0.99, P(0.001). These results indicated that PA and -Sm were immunologically identical and that serum PA and -Sm determined by immunoassays using anti-PA antibody and anti--Sm antibody should be evaluated as identical tumor markers for serodiagnosis of prostate cancer.